Aeglea Biotherapeutics Inc. appointed Ivana Magovcevic-Liebisch as a director.

Magovcevic-Liebisch is the executive vice president and chief business officer of Ipsen SA, a global biopharmaceutical company.

Austin, Texas-based Aeglea Biotherapeutics is a biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer.